Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. For more information, visit the company’s website or download their investor presentation. MedXtractor Corp.’s Looking Ahead.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

AUGUST 22, 2021

Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. The company believes that the same homing peptide approach could improve the safety and efficacy of psychedelic treatments. Silo Pharma Inc. Looking to the Future. Silo Pharma Inc.

Clinical Trials 105

Clinical Trials Research and Development Safety Treatment 105

Greencamp

FEBRUARY 17, 2019

Many people are using cannabis for IBS with great success in managing symptoms like nausea, cramps and stomach pains. The science and research behind cannabis and IBS has linked the imbalances of our endocannabinoid system with certain IBS symptoms. This is where compounds from cannabis make their entrance. Here’s how.

Digestion 96

Digestion Research and Development Marijuana Cannabinoids 96

Cannabis Law Report

NOVEMBER 24, 2019

Cannabis-based medicinal products. Severe treatment-resistant epilepsy. Severe treatment-resistant epilepsy. Consider nabilone as an add-on treatment for adults (18 years and over) with chemotherapy-induced nausea and vomiting which persists with optimised conventional antiemetics. Tools and resources. Recommendations.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

DECEMBER 9, 2021

The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I’m proud of our accomplishments to date and look forward to kicking off multiple clinical trials in early 2022,” said CEO, Josh Bartch. DENVER, Dec. DENVER, Dec.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

DECEMBER 21, 2021

Prakat swiftly modernizes legacy business hardware, software programs, and downloadable apps. Ignite products are ecologically responsible and do not require additional wastewater treatment. With instant screening test results, both patient and physician receive precious time to develop treatment plans.

Research and Development 52

Research and Development Supply Chain Data Business 52